167 related articles for article (PubMed ID: 23593330)
1. EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference.
Chen C; Mei H; Shi W; Deng J; Zhang B; Guo T; Wang H; Hu Y
PLoS One; 2013; 8(4):e60860. PubMed ID: 23593330
[TBL] [Abstract][Full Text] [Related]
2. Efficient nanoparticle mediated sustained RNA interference in human primary endothelial cells.
Mukerjee A; Shankardas J; Ranjan AP; Vishwanatha JK
Nanotechnology; 2011 Nov; 22(44):445101. PubMed ID: 21990205
[TBL] [Abstract][Full Text] [Related]
3. EGFP-EGF1-conjugated poly (lactic-co-glycolic acid) nanoparticles as a carrier for the delivery of CCR2- shRNA to atherosclerotic macrophage in vitro.
Wu Z; Chen C; Luo J; Davis JRJ; Zhang B; Tang L; Shi W; Liao D
Sci Rep; 2020 Nov; 10(1):19636. PubMed ID: 33184330
[TBL] [Abstract][Full Text] [Related]
4. EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis.
Wu Z; Chen C; Zhang B; Tang L; Shi W; Liao D; Di G; Davis JR; Wang H
Int J Nanomedicine; 2019; 14():2609-2618. PubMed ID: 31043777
[TBL] [Abstract][Full Text] [Related]
5. SiRNA drug delivery by biodegradable polymeric nanoparticles.
Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
[TBL] [Abstract][Full Text] [Related]
6. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
7. A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy.
Shi W; Yin Y; Wang Y; Zhang B; Tan P; Jiang T; Mei H; Deng J; Wang H; Guo T; Pang Z; Hu Y
Oncotarget; 2017 May; 8(19):32212-32227. PubMed ID: 27793028
[TBL] [Abstract][Full Text] [Related]
8. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Antitumor Activity of EGFP-EGF1-Conjugated Nanoparticles by a Multitargeting Strategy.
Zhang B; Jiang T; Ling L; Cao Z; Zhao J; Tuo Y; She X; Shen S; Jiang X; Hu Y; Pang Z
ACS Appl Mater Interfaces; 2016 Apr; 8(14):8918-27. PubMed ID: 26890991
[TBL] [Abstract][Full Text] [Related]
10. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
[TBL] [Abstract][Full Text] [Related]
11. A tissue factor targeted nanomedical system for thrombi-specific drug delivery.
Shi W; Mei H; Deng J; Chen C; Wang H; Guo T; Zhang B; Li L; Pang Z; Jiang X; Shen S; Hu Y
Biomaterials; 2012 Oct; 33(30):7643-54. PubMed ID: 22819496
[TBL] [Abstract][Full Text] [Related]
12. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.
Pantazis P; Dimas K; Wyche JH; Anant S; Houchen CW; Panyam J; Ramanujam RP
Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444
[TBL] [Abstract][Full Text] [Related]
13. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.
Nguyen J; Steele TW; Merkel O; Reul R; Kissel T
J Control Release; 2008 Dec; 132(3):243-51. PubMed ID: 18619502
[TBL] [Abstract][Full Text] [Related]
14. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
Lokras A; Foged C; Thakur A
Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
[TBL] [Abstract][Full Text] [Related]
15. Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation.
Jensen DM; Cun D; Maltesen MJ; Frokjaer S; Nielsen HM; Foged C
J Control Release; 2010 Feb; 142(1):138-45. PubMed ID: 19840823
[TBL] [Abstract][Full Text] [Related]
16. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
17. Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation.
Frede A; Neuhaus B; Knuschke T; Wadwa M; Kollenda S; Klopfleisch R; Hansen W; Buer J; Bruder D; Epple M; Westendorf AM
Nanomedicine; 2017 Nov; 13(8):2395-2403. PubMed ID: 28800875
[TBL] [Abstract][Full Text] [Related]
18. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
19. Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.
Steinbach JM; Weller CE; Booth CJ; Saltzman WM
J Control Release; 2012 Aug; 162(1):102-10. PubMed ID: 22705461
[TBL] [Abstract][Full Text] [Related]
20. Multicompartmental particles for combined imaging and siRNA delivery.
Misra AC; Bhaskar S; Clay N; Lahann J
Adv Mater; 2012 Jul; 24(28):3850-6. PubMed ID: 22581730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
